DermWireTV: Birch Triterpenes Gel Gets FDA Approval for EB, VTE Risk is Lower in Patients with AD, and Are Topical Steroids Affecting Bone Health?

DermWireTV Birch Triterpenes T Gel Gets FDA Approval for EB VTE Risk is Lower in Patients with AD and Are Topical Steroids Af
Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Register

We're glad to see you're enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free